# A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)

> **NCT01376778** · PHASE3 · COMPLETED · sponsor: **The George Washington University Biostatistics Center** · enrollment: 399 (actual)

## Conditions studied

- Congenital Cytomegalovirus Infection
- Maternal Cytomegalovirus Infection

## Interventions

- **DRUG:** CMV hyperimmune globulin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01376778
- **Lead sponsor:** The George Washington University Biostatistics Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2019-10
- **Final completion:** 2021-06-30
- **Target enrollment:** 399 (ACTUAL)
- **Last updated:** 2023-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376778, "A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01376778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*